144 related articles for article (PubMed ID: 23551036)
1. Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma.
Sayki Arslan M; Sahin M; Topaloglu O; Tutal E; Karakose M; Gungunes A; Cakal E; Ozbek M; Delibasi T
Clin Endocrinol (Oxf); 2013 Dec; 79(6):882-6. PubMed ID: 23551036
[TBL] [Abstract][Full Text] [Related]
2. Are there any causes for increased thyroid volume in women with prolactinoma?
Doğan BA; Taşcı T; Arduç A; Müslüm Tuna M; Berker D; Güler S
Ann Endocrinol (Paris); 2015 Oct; 76(5):595-600. PubMed ID: 26067294
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hypothyroidism is three times more frequent in female prolactinoma patients compared to healthy women: data from a cross-sectional case-control study.
Elenkova A; Аtanasova I; Кirilov G; Natchev Е; Ivanova R; Кovatcheva R; Vandeva S; Tcharaktchiev D; Zacharieva S
Endocrine; 2017 Sep; 57(3):486-493. PubMed ID: 28726182
[TBL] [Abstract][Full Text] [Related]
4. The association of autoimmune thyroiditis and non-functional adrenal incidentalomas with insulin resistance.
Karakose M; Karbek B; Sahin M; Arslan MS; Topaloglu O; Erden G; Demirci T; Calıskan M; Delibasi T
Arch Endocrinol Metab; 2015 Feb; 59(1):42-6. PubMed ID: 25926113
[TBL] [Abstract][Full Text] [Related]
5. The influence of other than prolactin hormones on bone mineral density in women with hyperprolactinaemia of various origins.
Bolanowski M; Zadrozna-Sliwka B; Jawiarczyk A; Syrycka J
Gynecol Endocrinol; 2010 Aug; 26(8):623-7. PubMed ID: 20218822
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
Poyraz BC; Aksoy C; Balcioğlu I
Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
[TBL] [Abstract][Full Text] [Related]
8. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure.
Bülow Pedersen I; Laurberg P; Knudsen N; Jørgensen T; Perrild H; Ovesen L; Rasmussen LB
Clin Endocrinol (Oxf); 2005 Jun; 62(6):713-20. PubMed ID: 15943834
[TBL] [Abstract][Full Text] [Related]
9. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study.
Onal ED; Saglam F; Sacikara M; Ersoy R; Cakir B
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):48-52. PubMed ID: 24728164
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies.
Peluso R; Lupoli GA; Del Puente A; Iervolino S; Bruner V; Lupoli R; Di Minno MN; Foglia F; Scarpa R; Lupoli G
J Rheumatol; 2011 Jul; 38(7):1371-7. PubMed ID: 21498480
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
[TBL] [Abstract][Full Text] [Related]
12. The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas.
Dogansen SC; Selcukbiricik OS; Bilir BE; Yarman S
Growth Horm IGF Res; 2016 Aug; 29():45-49. PubMed ID: 27105040
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinaemia attenuates the inhibitory effect of vitamin D/selenomethionine combination therapy on thyroid autoimmunity in euthyroid women with Hashimoto's thyroiditis: A pilot study.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharm Ther; 2020 Dec; 45(6):1334-1341. PubMed ID: 32649802
[TBL] [Abstract][Full Text] [Related]
14. Interrelationship between TSH- and prolactin secretion in patients with prolactinoma and autoimmune thyroiditis.
Pelkonen R; Salmi J; Lamberg BA
Acta Endocrinol (Copenh); 1982 Jun; 100(2):184-8. PubMed ID: 6810613
[TBL] [Abstract][Full Text] [Related]
15. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
[TBL] [Abstract][Full Text] [Related]
16. The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
Gynecol Endocrinol; 2009 Dec; 25(12):799-806. PubMed ID: 19905999
[TBL] [Abstract][Full Text] [Related]
17. Macroprolactinaemia associated with prolactin adenoma.
Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
[TBL] [Abstract][Full Text] [Related]
18. Thyroid autoantibodies in autoimmune diseases.
Innocencio RM; Romaldini JH; Ward LS
Medicina (B Aires); 2004; 64(3):227-30. PubMed ID: 15239536
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
[TBL] [Abstract][Full Text] [Related]
20. Anti-thyroid antibodies in patients with hyperprolactinemia.
Ishibashi M; Kuzuya N; Sawada S; Kitamura K; Kamoi K; Yamaji T
Endocrinol Jpn; 1991 Oct; 38(5):517-22. PubMed ID: 1843271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
